Prometheus Biosciences, Inc.
GPR35 modulators
Last updated:
Abstract:
Described herein are GPR35 modulators and methods of using these compounds in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
Status:
Grant
Type:
Utility
Filling date:
23 Jan 2020
Issue date:
6 Jul 2021